Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 2
2004 1
2006 3
2007 2
2008 3
2009 1
2011 2
2012 1
2013 1
2014 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders.
Dorgalaleh A, Farshi Y, Haeri K, Ghanbari OB, Ahmadi A. Dorgalaleh A, et al. Semin Thromb Hemost. 2022 Apr;48(3):344-355. doi: 10.1055/s-0041-1740566. Epub 2022 Jan 6. Semin Thromb Hemost. 2022. PMID: 34991167
Risk factors that can affect the occurrence of ICH include the type of bleeding disorder and its severity, genotype and genetic polymorphisms, type of delivery, and sports and other activities. Patients with hemophilia A; afibrinogenemia; FXIII, FX, and FVII deficie …
Risk factors that can affect the occurrence of ICH include the type of bleeding disorder and its severity, genotype and genetic polym …
Principles of care for the diagnosis and treatment of von Willebrand disease.
Castaman G, Goodeve A, Eikenboom J; European Group on von Willebrand Disease. Castaman G, et al. Haematologica. 2013 May;98(5):667-74. doi: 10.3324/haematol.2012.077263. Haematologica. 2013. PMID: 23633542 Free PMC article. Review.
Desmopressin is the treatment of choice for type 1 von Willebrand disease patients with factor VIII and von Willebrand factor levels of 10 U/dL or over who have proved responsive to a test-infusion with the compound. Von …
Desmopressin is the treatment of choice for type 1 von Willebrand disease patients with factor VIII and …
Advances in the diagnosis and management of type 1 von Willebrand disease.
Castaman G, Rodeghiero F. Castaman G, et al. Expert Rev Hematol. 2011 Feb;4(1):95-106. doi: 10.1586/ehm.11.1. Expert Rev Hematol. 2011. PMID: 21322782 Review.
Von Willebrand disease (VWD) is an autosomally inherited bleeding disorder caused by a deficiency and/or abnormality of von Willebrand factor (VWF). ...The diagnosis of VWD may be difficult, especially in type 1 disease, sin …
Von Willebrand disease (VWD) is an autosomally inherited bleeding disorder caused by a deficiency and/or abnormality of …
Treatment of von Willebrand disease.
Mannucci PM. Mannucci PM. Haemophilia. 1998 Jul;4(4):661-4. doi: 10.1046/j.1365-2516.1998.440661.x. Haemophilia. 1998. PMID: 9873811 Review.
von Willebrand disease is the most frequent of inherited bleeding disorders (1:100 affected individuals in the general population). ...Desmopressin is the treatment of choice in patients with type 1 von Willebrand disease …
von Willebrand disease is the most frequent of inherited bleeding disorders (1:100 affected individuals in the g …
Common management issues in pediatric patients with mild bleeding disorders.
O'Brien SH. O'Brien SH. Semin Thromb Hemost. 2012 Oct;38(7):720-6. doi: 10.1055/s-0032-1326787. Epub 2012 Oct 3. Semin Thromb Hemost. 2012. PMID: 23034827 Review.
Type 1 von Willebrand disease and mild platelet function defects are among the most common disorders seen by pediatric hematologists. ...This review will discuss the published literature and provide practical suggestions regarding four common ma …
Type 1 von Willebrand disease and mild platelet function defects are among the most common disorders seen …
Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population.
Hyatt SA, Wang W, Kerlin BA, O'Brien SH. Hyatt SA, et al. Pediatr Blood Cancer. 2009 Jan;52(1):102-7. doi: 10.1002/pbc.21755. Pediatr Blood Cancer. 2009. PMID: 18816699
BACKGROUND: Definitive diagnosis of type 1 von Willebrand disease (VWD) remains elusive in clinical practice. ...PROCEDURE: We performed a retrospective medical record review of all type 1 VWD patients at a single children's hospit …
BACKGROUND: Definitive diagnosis of type 1 von Willebrand disease (VWD) remains elusive in clinical pract …
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U. Michiels JJ, et al. Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399. Clin Appl Thromb Hemost. 2007. PMID: 17164493 Free article. Review.
The current standard set of von Willebrand factor (VWF) parameters used to differentiate type 1 from type 2 VWD include bleeding times (BTs), factor VIII coagulant activity (FVIII:C), VWF antigen (VWF:Ag), VWF ristocetine cofactor activity (VWF: …
The current standard set of von Willebrand factor (VWF) parameters used to differentiate type 1 from type …
Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience.
Goudemand J, Negrier C, Ounnoughene N, Sultan Y. Goudemand J, et al. Haemophilia. 1998;4 Suppl 3:48-52. doi: 10.1046/j.1365-2516.1998.0040s3048.x. Haemophilia. 1998. PMID: 10028319
Since 1989 this concentrate has been routinely used in clinical practice taking into account the vWF:RCoF given by the manufacturer. Seventy-five patients with von Willebrand disease (type 1: 42, 2A: 11, 2B: 5, 2N: 6, 3: 4, acquired: 7) were tre …
Since 1989 this concentrate has been routinely used in clinical practice taking into account the vWF:RCoF given by the manufacturer. Seventy …
Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease.
Robertson JD, Yenson PR, Rand ML, Blanchette VS, Carcao MD, Notley C, Lillicrap D, James PD. Robertson JD, et al. J Thromb Haemost. 2011 Sep;9(9):1752-60. doi: 10.1111/j.1538-7836.2011.04423.x. J Thromb Haemost. 2011. PMID: 21711445 Free article.
BACKGROUND: Recent phenotype-genotype studies have provided valuable insights into the pathophysiology of type 1 von Willebrand disease (VWD); however, no study has examined an exclusively pediatric cohort. OBJECTIVES: To describe phenotype-geno …
BACKGROUND: Recent phenotype-genotype studies have provided valuable insights into the pathophysiology of type 1 von …
Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease.
Quiroga T, Goycoolea M, Belmont S, Panes O, Aranda E, Zúñiga P, Pereira J, Mezzano D. Quiroga T, et al. J Thromb Haemost. 2014 Aug;12(8):1238-43. doi: 10.1111/jth.12594. Epub 2014 Jun 27. J Thromb Haemost. 2014. PMID: 24796601 Free article.
INTRODUCTION: Only 50% of patients with type 1 von Willebrand disease (VWD) have recognized molecular defects and diagnosis still rests on demonstrating low plasma von Willebrand factor (VWF) protein/function. ...Diagnostic criteri …
INTRODUCTION: Only 50% of patients with type 1 von Willebrand disease (VWD) have recognized molecular def …
19 results